Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosis

Compounds and pharmaceutical compositions thereof for the treatment of cystic fibrosis

US Patent 9382254 · Granted Jul 5, 2016

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compounds and pharmaceutical compositions thereof for the treatment of inflammat2025
Compounds and pharmaceutical compositions thereof for the treatment of inflammat2025
Compound useful for the treatment of degenerative and inflammatory diseases2024
Compounds and pharmaceutical compositions thereof for the treatment of inflammat2023
Compounds and pharmaceutical compositions thereof for the treatment of inflammat2023
Compound useful for the treatment of degenerative and inflammatory diseases2021
Modulators of the cystic fibrosis transmembrane conductance regulator protein an2021
Modulators of the cystic fibrosis transmembrane conductance regulator protein an2021
Modulators of the cystic fibrosis transmembrane conductance regulator protein an2020
Modulators of the cystic fibrosis transmembrane conductance regulator protein an2020
Modulators of the cystic fibrosis transmembrane conductance regulator protein an2020
N-sulfonylated-pyrazolo[3,4-b]pyridin-6-carboxamides and method of use2020